Protective effect of inducible type nitric oxide synthase against intracellular oxidative stress caused by advanced glycation end-products in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats

Journal of Hypertension

Volumn 18, Issue 8, 2000, Pages 1071-1079

  Mizutani, Kenichi ^a   Ikeda, Katsumi ^a   Ito, Tamiyo ^a   Tamaki, Katsunori ^b   Nara, Yasuo ^c   Yamori, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KONAN UNIVERSITY   (Japan)

^c UNIVERSITY OF EAST ASIA   (Japan)

Author keywords

Glutathione; Nitric oxide; Oxidative stress; Stroke prone spontaneously hypertensive rats; Vascular smooth muscle cells

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; INTERLEUKIN 1BETA; LINSIDOMINE; MESSENGER RNA; N ACETYL S NITROSOPENICILLAMINE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 0033851503     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200018080-00012     Document Type: Article

References (61)

1. Biomarker evidence of DNA oxidation in lung cancer with radiotherapy, chemotherapy, and response to treatment
2. Free radicals, oxidative low density lipoprotein (LDL), and the heart: Antioxidants and other strategies to limit cardiovascular damage
3. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension
4. Antioxidant status and lipid peroxidation in patients with essential hypertension
5. Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension
6. Nonenzymatic glycosylation and the pathogenesis of diabetic complications
7. The chemistry of the maillard reaction under physiological conditions: A review
8. Chemical pathways of the maillard reaction
9. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation end products of the rat aorta in relation to age
10. Biomechanical properties and chemical composition of the aorta in genetic hypertensive rats
11. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia
12. Differential effects of type 2 (non-insulin-dependent) diabetes mellitus on pentosidine formation in skin and glomerular basement membrane
13. Advanced glycation end product-induced activation of NFkB is suppressed by α-lipoic acid in cultured endothelial cells
14. Advanced glycation end products stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth msucle cells
15. Involvement of glycation and oxidative stress in diabetic macroangiopathy
16. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage
17. Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions
18. The endothelial cell binding site for advanced glycation end products consist of a complex: An integral membrane protein and a lactoferrin-like polypeptide
19. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells
20. The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells
21. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
22. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats
23. Pathogenesis of spontaneously hypertension as a model for essential hypertension
24. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium
25. Effect of glycated collagen on proliferation of human smooth muscle cells in vitro
26. Collagen aging in vitro by nonenzymatic glycosylation and browning
27. Methods for assaying nonenzymatic glycosylation
28. ELISA of pentosidine, an advanced glycation end product, in biological specimens
29. Production of hydrogen peroxide by transforming growth factor-βl and its involvement in induction of egr-1 in mouse osteoblastic cells
30. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation
31. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages
32. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
33. Reciprocal control of T helper cell and dendritic cell differentiation
34. Induction of Max by and calcitonin gene-related peptide antagonizes endothelial apoptosis
35. Rapid titer determination using quantitative real-time PCR
36. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells
37. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
38. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite
39. Pathogenetic effects of advanced glycosylation: Biochemical, biological and clinical implications for diabetes and aging
40. Structural elucidation of a senescence cross link from human extracellular matrix
41. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
42. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries
43. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
44. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
45. Nitric oxide produced by human B lympocytes inhibits apoptosis and Epstein·Barr virus reactivation
46. Regulation of cellular glutathione
47. Quinone-induced oxidative Stress elevates glutathione and induces gamma-glutamylcysteine synthetase activity in rat lung epithelial L2 cells
48. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle
49. Cell age distribution of erythrocytes at the incidence of cerebral stroke in stroke-prone spontaneously hypertensive rats, and their glutathione peroxidase activity
50. Effects of antihypertensive drugs on rat tissue antioxidant enzyme activities and lipid peroxidation levels
51. Does superoxide underlie the pathogenesis of hypertension?
52. Increased oxidative DNA damage in stroke-prone spontaneously hypertensive rats (SHRSP)
53. Two-weeks administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2α
54. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins
55. Advanced glycation end products (AGEs) on the surface of diabetic erthrocytes to the vessel wall via a specific receptor inducing oxidative stress in the vasculature: A link between surface-associated AGEs and diabetic complications
56. Effect of nitric oxide on hydrogen peroxide-induced damage in isolated rabbit gastric glands
57. Nitric oxide protects against alkyl peroxide-mediated cytotoxicity: Further insights into the role nitric oxide plays in oxidative stress
58. Nitric oxide synthesis is impaired in glutathione-depleted human umbilical vein endothelial cells
59. Nitric oxide-dependent induction of glutathione synthesis through increased expression of γ-glutamylcysteine synthetase
60. Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion
61. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines